Streptococcus pneumoniae resistance to fluoroquinolones [6]

Lancet

Volumn 348, Issue 9042, 1996, Pages 1660-

  Wise, R ^a   Brenwald, N ^a   Gill, M ^a   Fraise, A ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4,3,0]NON 8 YL) 6 FLUORO 8 METHOXY 1,4 DIHYDRO 4 OXO 3 QUINOLINE; CIPROFLOXACIN; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; CONTROLLED STUDY; GENE MUTATION; LETTER; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030471490     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65724-8     Document Type: Letter

References (4)

1. J Child J Andrews F Boswell NP Brenwald R Wise The in vitro activity ofCP 99,219, a new naphthyridone antimicrobial agent JAntimicrob Chemother 35 1995 869 876
2. Petersen U, Bremm KD, Dalhoff A, et al. Synthesis in BAY 12-8039, a new 8-methoxy-quinolone. Abst no F1. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans. Sept 15–18, 1996.
3. Report of the Working Party on Antimicrobial Sensitivity Testing of the British Society for Chemotherapy 1991 Academic Press London
4. X-S Pan J Ambler S Mehtar LM Fisher Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae Antimicrob Agents Chemother 40 1996 2321 2326